MAP2K7 and melanoma: Finally, another study demonstrated that the combination of leflunomide and selumetinib (an inhibitor of MEK) had a synergic effect in reducing BRAFwt and mutant melanoma cells’ proliferation and growth of melanoma tumors in xenografted mice (28).